Hepcvel Tablet, For Clinical Hospital

Hepcvel Sofosbuvir and Velpatasvir Tablet is a combination medication used to treat chronic hepatitis C virus (HCV) infection in adults. The tablet contains two active ingredients, Sofosbuvir and Velpatasvir, which work together to prevent the spread of HCV in the body.

Active Ingredients :

Hepcvel Sofosbuvir and Velpatasvir Tablet contains Sofosbuvir and Velpatasvir as the active ingredients. Sofosbuvir works by inhibiting the replication of the HCV virus in the body, while Velpatasvir prevents the virus from spreading and multiplying.

Dosage :

The recommended dosage of Hepcvel Sofosbuvir and Velpatasvir Tablet is one tablet taken orally once daily with or without food. The duration of treatment varies depending on the patient's medical history and the severity of the infection. It is essential to follow the recommended dosage and consult a healthcare professional before starting the medication.

Usage :

Hepcvel Sofosbuvir and Velpatasvir Tablet is used to treat chronic HCV infection in adults. The medication is typically administered by a healthcare professional in a hospital or clinic setting.

Effectiveness :

Hepcvel Sofosbuvir and Velpatasvir Tablet has been clinically proven to be an effective treatment for chronic HCV infection. It has been shown to eliminate the virus from the body in up to 95% of cases, reducing the risk of liver damage and improving patient outcomes.